Cargando…
COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma
Osteosarcoma is the most common skeletal malignancy and is the second leading cause of cancer death in adolescents. Its highly aggressive nature and high propensity to metastasize lead to an extremely poor prognosis for patients with osteosarcoma. Therefore, finding a suitable treatment has become a...
Autores principales: | Han, Yan-Long, Luo, Dan, Habaxi, Kakeng, Tayierjiang, Julaiti, Zhao, Wei, Wang, Wei, Aikebaier, Wumaierjiang, Wang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907856/ https://www.ncbi.nlm.nih.gov/pubmed/35280775 http://dx.doi.org/10.3389/fonc.2022.813809 |
Ejemplares similares
-
TGF-β1 enhanced myocardial differentiation through inhibition of the Wnt/β-catenin pathway with rat BMSCs
por: Lv, Yang, et al.
Publicado: (2020) -
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2022) -
Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway
por: Tan, Tao, et al.
Publicado: (2019) -
ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β‐catenin signalling pathways
por: Huang, Hai, et al.
Publicado: (2020) -
Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/β-Catenin and EMT Signaling Pathway
por: Mao, Xiaohan, et al.
Publicado: (2020)